JP Morgan Chase
CGNT

JP Morgan Chase’s Cogentix Medical, Inc. CGNT Stock Holding History

JP Morgan Chase’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,300
Closed -$17K – 5778
2017
Q4 		$17K Buy
5,300
+300
+6% +$865 ﹤0.01% 5192
2017
Q3 		$13K Hold
5,000
– – ﹤0.01% 4690
2017
Q2 		$9K Hold
5,000
– – ﹤0.01% 4687
2017
Q1 		$9K Buy
+5,000
New +$9.88K ﹤0.01% 4833

Other funds holding CGNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's CGNT Position: Q1 2018 in Review

JP Morgan Chase sold out of Cogentix Medical, Inc. (CGNT) in Q1 2018, closing a stake of 5,300 shares — an estimated $17K sold.

JP Morgan Chase first reported a position in CGNT in Q1 2017 and held it in 4 quarters. The position peaked at $17K in Q4 2017. 47 funds tracked by Wall St. Rank hold CGNT as of Q1 2018.

  • JP Morgan Chase reported no remaining Cogentix Medical, Inc. position as of Q1 2018 after selling out during the quarter.
  • JP Morgan Chase sold 5,300 Cogentix Medical, Inc. shares in Q1 2018, an estimated $17K.
  • JP Morgan Chase first reported a position in Cogentix Medical, Inc. in Q1 2017 and held it in 4 quarters.
  • JP Morgan Chase's Cogentix Medical, Inc. position peaked at $17K in Q4 2017.
  • 47 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q1 2018.

Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.